Table 3 Late clinical outcomes
From: Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation
Variables | All (n = 338) | Non-TR group (n = 307) | TR group (n = 31) | p |
|---|---|---|---|---|
Hemodialysis | 34 (10.1%) | 24 (7.8%) | 10 (32.3%) | < 0.01 |
The number of times of biopsies | 15.1 ± 6.5 | 14.9 ± 6.2 | 17.7 ± 8.1 | 0.02 |
Rejection ≧ grade 2 | 105 (31.1%) | 88 (28.7%) | 17 (54.8%) | < 0.01 |
CVP (mmHg) | 6.9 ± 4.6 | 6.6 ± 3.8 | 10.3 ± 8.7 | < 0.01 |
Mean PAP (mmHg) | 22.7 ± 7.5 | 22.1 ± 6.7 | 28.1 ± 12.0 | < 0.01 |
PAWP (mmHg) | 13.4 ± 5.9 | 12.9 ± 5.0 | 17.9 ± 10.4 | < 0.01 |
PAPi | 3.61 ± 3.2 | 3.62 ± 3.2 | 3.54 ± 2.9 | 0.90 |
CVP/PAWP | 0.53 ± 0.7 | 0.54 ± 0.7 | 0.52 ± 0.2 | 0.97 |
CI (L/min/m2) | 3.17 ± 0.7 | 3.21 ± 0.7 | 2.77 ± 0.7 | < 0.01 |